| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $278K | -75.8% |
| SG&A Expense | $718K | +127.9% |
| Operating Income | -$28.8M | -613.8% |
| Interest Expense | $1.1M | +139.9% |
| Pre-tax Income | -$24.7M | -461.3% |
| Income Tax | $33K | — |
| Net Income | -$24.7M | -460.7% |
| EPS (Basic) | -$2.30 | -3185.7% |
| EPS (Diluted) | -$2.30 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.0M | — |
| Current Assets | $2.4M | +637.3% |
| Total Assets | $20.3M | -54.5% |
| Current Liabilities | $9.8M | -25.5% |
| Total Liabilities | $13.1M | -20.3% |
| Stockholders' Equity | $4.3M | -83.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | -37.5% |
| Investing Cash Flow | $2K | +113.3% |
| Financing Cash Flow | $5.9M | +106.5% |
| -3185.7% |